Danish pharma large Novo Nordisk teased promising early-stage trial final results of its experimental weight loss tablet amycretin, sending the organization’s stock surging.“Especially for new medicines like copyright, prices can modify all the time due to the fact organizations compete to promote the medicine,” Dr. Kelvas points out. “I Ch